Search

everythinglearnresearchcommunity

for

Search:↓

PRP treatment for hair loss shows promise, with 58% of patients satisfied and most noticing improvement within 6 months.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Long-term finasteride use doesn't change bone density or metabolism.

RT1640 treatment reverses gray hair and promotes hair growth in mice.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Applying latanoprost on skin can stimulate hair growth with minimal side effects.

Azelaic Acid is effective and safe for treating adult female acne, with few side effects.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.

Some botanical products may help increase hair growth in people with alopecia, but more research is needed.

Finasteride increases hair weight and count in men with hair loss, with best results after four years.

Latanoprostene bunod effectively lowers eye pressure and is better tolerated than other glaucoma medications.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

Itraconazole-loaded nanoparticles are more effective and less toxic for treating fungal infections than conventional oral itraconazole.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Azathioprine caused side effects in over half of the Korean pediatric inflammatory bowel disease patients, requiring close monitoring.